BMED vs HEAL: Holdings Overlap & Returns
Over the year to Nov 13, 2026, BMED returned +25.4% to HEAL's +0.2%; 7% of their weight is in the same names.
- Return gap
- +25.2 pts1 year to Nov 13, 2026: BMED ahead, total return
- Fee gap
- 0.05 ptsA year: BMED 0.55%, HEAL 0.50%, per filings dated Nov 21, 2025 and Mar 27, 2026
- Overlap
- 7%Share of the two books held in common, holdings dated Nov 12, 2026 and Nov 11, 2026
- Net flow
- –Needs daily flows for both funds
Compare two other funds
Growth of 100
Drawn from the numbers on this page. Growth of 100, both funds, distributions reinvested
BMED +25.4%, HEAL +0.2%: BMED +25.2 pts ahead, 1 year, Nov 13, 2025 to Nov 13, 2026.
ShareUse this comparison
Cost to trade
Hypothetical. A $10,000 order in BMED costs about $11.50 one way and $23.00 in and out, at a median spread of 0.23%. The 0.23% spread is BMED’s 30-day median, from iShares (fund page).
Fees over time
Hypothetical. $10,000 in BMED for 10 years at 0.55% a year costs about $908 in fees and lost growth; HEAL at 0.50% would cost $827. Assumes 6% a year before fees, a sample rate, not a forecast.
How each fund moved
58% of BMED's weight is in S&P 500 companies and 42% is outside the index. Holdings as of Nov 12, 2026.
27% of HEAL's weight is in S&P 500 companies and 73% is outside the index. Holdings as of Nov 11, 2026.
Key numbers
HEAL costs 0.05 points a year less; their one-year returns differ by 25.2 points; HEAL is 2.5 times larger.
Pair scorecard
Open the table
Points (pts) are percentage points.
| Total return, 1 year | +25.4% | +0.2% |
|---|---|---|
| Below its all-time high | 55.5%, high on Feb 12, 2021 | |
| What it tracks | Healthcare innovation and GLP-1 | Healthcare innovation and GLP-1 |
| Expense ratio | 0.55% | 0.50% |
| Net assets, as of Nov 11, 2026 | $15m | $38m |
| Holdings in common | 7% |
The numbers behind it
Net assets: $15m on Nov 13, 2026 for iShares Health Innovation Active ETF, and $38m on Nov 11, 2026 for Global X HealthTech ETF.
Holdings in common uses holdings dated Nov 11, 2026 and Nov 12, 2026.
What they share
By the books each fund has filed, BMED and HEAL hold 7% of their money in the same securities at the same weight. Holdings dated Nov 11, 2026 and Nov 12, 2026.
half
7% in common
Held in common
Show all 3 holdings
| IQVIA HOLDINGS INC | 3.58% | 6.00% |
| DEXCOM INC | 2.17% | 4.51% |
| TEMPUS AI CLASS A | 0.91% | 4.98% |
Only in BMED
Show all 8 holdings
| GILEAD SCIENCES | 5.80% |
| MODERNA | 5.52% |
| DANAHER | 5.15% |
| ABBVIE | 4.91% |
| THERMO FISHER SCIENTIFIC | 4.33% |
| EDWARDS LIFESCIENCES | 4.25% |
| BIOGEN | 3.70% |
| METTLER-TOLEDO INTERNATIONAL INC | 3.61% |
Only in HEAL
Show all 8 holdings
| VEEVA SYSTEMS INC-CLASS A | 6.13% |
| OSCAR HEALTH INC - CLASS A | 5.62% |
| PRO MEDICUS LTD | 4.98% |
| GE HEALTHCARE TECHNOLOGY | 4.66% |
| RESMED INC | 4.00% |
| KONINKLIJKE PHILIPS NV | 3.94% |
| WAYSTAR HOLDING CORP | 3.83% |
| DEMANT A/S | 3.71% |
Side by side
Open the table
| Fund | iShares Health Innovation Active ETF · Holds 55 stocks in healthcare innovation and GLP-1, 58% of its weight in S&P 500 companies | Global X HealthTech ETF · Holds 39 stocks in healthcare innovation and GLP-1, 27% of its weight in S&P 500 companies |
| Issuer | iShares | Global X |
| Theme | Healthcare innovation and GLP-1 | Healthcare innovation and GLP-1 |
| In the S&P 500 | 58.2% | 27.0% |
| Active share vs the S&P 500 | 95.6% | 99.6% |
| In the Nasdaq-100 | 13.8% | 7.9% |
| Holdings | 55 | 39 |
| Top ten, share of the fund | 44.1% | 48.6% |
| Expense ratio | 0.55% | 0.50% |
| Fee for the differing part | 0.58% | 0.50% |
| Total return, 1 year | +25.4% | +0.2% |
| vs its benchmark | not measured | not measured |
| Below its high | −2.7% | −55.5% |
| Net assets, BMED as of Nov 13, 2026 and HEAL as of Nov 11, 2026 | $15m | $38m |
As of Nov 13, 2026. Source: ETFIQ.
Window by window
Open the table
| 3 months | +12.9% | +2.9% |
|---|---|---|
| 6 months | +33.6% | +24.6% |
| 1 year | +25.4% | +0.2% |
| 3 years | +68.1% | +15.7% |
| Since launch (Not the same days: BMED Oct 2020 · HEAL Jul 2020) | +42.8% | −35.3% |
About BMED
By weight, 58% of BMED's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 96%. The top ten holdings are 44% of the fund across 55 positions, as published by its issuer for Nov 12, 2026.
More
Over the year to Nov 13, 2026 the fund returned +25.4% with distributions reinvested.
About HEAL
By weight, 27% of HEAL's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 100%. The top ten holdings are 49% of the fund across 39 positions, as published by its issuer for Nov 11, 2026.
More
Over the year to Nov 13, 2026 the fund returned +0.2% with distributions reinvested. It sits 55.5% below its all-time high of Feb 12, 2021.
7% of the two portfolios are the same securities at the same weight.
Questions people ask
Do BMED and HEAL hold the same stocks?
By their latest filings, 7% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Other comparisons
Sources
More
Links are sources, not endorsements. A comparison is not a recommendation.
Copy and cite
Cite this pageCitation, APA and Markdown
ETFIQ, BMED against HEAL, data as of Nov 13, 2026. https://etfiq.com/compare/themes/bmed-vs-heal
ETFIQ. (Nov 13, 2026). BMED against HEAL. Retrieved from https://etfiq.com/compare/themes/bmed-vs-heal
[BMED against HEAL (ETFIQ, Nov 13, 2026)](https://etfiq.com/compare/themes/bmed-vs-heal)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.